Phase II trial evaluating axitinib for patients with unresectable, recurrent, or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Assuntina Gesualda Sacco, Lili Zhao, Thomas E. Carey, Irina Y. Dobrosotskaya, Jonathan B. McHugh, Douglas Brian Chepeha, Carol Rossier Bradford, Gregory T. Wolf, Mark E Prince, Jeffrey Moyer, Erin Lynn McKean, Scott A McLean, Kelly M Malloy, Matthew E Spector, Norman D Hogikyan, Susan Urba, Brent Ward, Francis P. Worden
Institutions: U-M Rogel Cancer Center, University of Michigan, Henry Ford Health
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2602104594